AU689346B2 - Direct fluorescence-conjugated immunoassay for platelet activation - Google Patents

Direct fluorescence-conjugated immunoassay for platelet activation

Info

Publication number
AU689346B2
AU689346B2 AU40168/95A AU4016895A AU689346B2 AU 689346 B2 AU689346 B2 AU 689346B2 AU 40168/95 A AU40168/95 A AU 40168/95A AU 4016895 A AU4016895 A AU 4016895A AU 689346 B2 AU689346 B2 AU 689346B2
Authority
AU
Australia
Prior art keywords
sample
platelets
samples
selectin
platelet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU40168/95A
Other languages
English (en)
Other versions
AU4016895A (en
Inventor
Bruce A. Kottke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WATSON CLINIC FOUNDATION
Original Assignee
WATSON CLINIC FOUNDATION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WATSON CLINIC FOUNDATION filed Critical WATSON CLINIC FOUNDATION
Publication of AU4016895A publication Critical patent/AU4016895A/en
Application granted granted Critical
Publication of AU689346B2 publication Critical patent/AU689346B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/7056—Selectin superfamily, e.g. LAM-1, GlyCAM, ELAM-1, PADGEM
    • G01N2333/70564—Selectins, e.g. CD62

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AU40168/95A 1994-10-25 1995-10-24 Direct fluorescence-conjugated immunoassay for platelet activation Ceased AU689346B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32847594A 1994-10-25 1994-10-25
US328475 1994-10-25
US47098095A 1995-06-06 1995-06-06
US470980 1995-06-06
PCT/US1995/014041 WO1996012956A1 (fr) 1994-10-25 1995-10-24 Dosage immunologique conjugue a une fluorescence directe et s'appliquant a l'activation plaquettaire

Publications (2)

Publication Number Publication Date
AU4016895A AU4016895A (en) 1996-05-15
AU689346B2 true AU689346B2 (en) 1998-03-26

Family

ID=26986392

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40168/95A Ceased AU689346B2 (en) 1994-10-25 1995-10-24 Direct fluorescence-conjugated immunoassay for platelet activation

Country Status (7)

Country Link
JP (1) JPH10512951A (fr)
AU (1) AU689346B2 (fr)
BR (1) BR9507579A (fr)
CA (1) CA2184826A1 (fr)
FI (1) FI963848A (fr)
NO (1) NO963780L (fr)
WO (1) WO1996012956A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0946877A1 (fr) * 1996-11-13 1999-10-06 Centocor, Inc. Dosages de p-selectine et procedes d'utilisation correspondants
GB2338236B (en) 1998-06-13 2003-04-09 Aea Technology Plc Microbiological cell processing
US7049140B1 (en) 1999-04-29 2006-05-23 Vanderbilt University X-ray guided drug delivery
US6159443A (en) * 1999-04-29 2000-12-12 Vanderbilt University X-ray guided drug delivery
JP2001131078A (ja) * 1999-11-09 2001-05-15 Iatron Lab Inc 新規活性固定化血小板及びその製造方法
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
US7306925B2 (en) 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
US6913932B2 (en) * 2002-08-23 2005-07-05 Beckman Coulter, Inc. Formaldehyde-ammonium salt complexes for the stabilization of blood cells
US20110250588A1 (en) * 2008-12-18 2011-10-13 Sysmex Corporation Method for detecting cancer cells in blood sample
EP3054936B1 (fr) 2013-10-10 2023-10-18 Eastern Virginia Medical School Dérivés de 4-((2-hydroxy-3-méthoxybenzyl)amino)benzènesulfonamide comme inhibiteur de la 12-lipoxygénase
US10449261B2 (en) 2014-07-24 2019-10-22 Washington University Compositions targeting radiation-induced molecules and methods of use thereof
FR3109999A1 (fr) * 2020-05-05 2021-11-12 Etablissement Français Du Sang Methode de detection de l’activation plaquettaire liee a l’inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783330A (en) * 1984-11-15 1988-11-08 New England Medical Center Hospitals, Inc. Monoclonal antibodies to activated platelets
US5030554A (en) * 1987-12-04 1991-07-09 Coulter Corporation Conservative whole blood sample preparation technique

Also Published As

Publication number Publication date
CA2184826A1 (fr) 1996-05-02
MX9604205A (es) 1998-05-31
NO963780D0 (no) 1996-09-10
FI963848A0 (fi) 1996-09-26
FI963848A (fi) 1996-09-26
AU4016895A (en) 1996-05-15
BR9507579A (pt) 1997-09-09
JPH10512951A (ja) 1998-12-08
WO1996012956A1 (fr) 1996-05-02
NO963780L (no) 1997-08-25

Similar Documents

Publication Publication Date Title
Michelson Flow cytometry: a clinical test of platelet function
Shattil et al. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry
Michelson et al. Evaluation of platelet function by flow cytometry
AU649027B2 (en) Fetal cell recovery method
CA2067916C (fr) Mode de detection de l'inflammation
US5385822A (en) Methods for detection and quantification of cell subsets within subpopulations of a mixed cell population
AU689346B2 (en) Direct fluorescence-conjugated immunoassay for platelet activation
US5529902A (en) Direct fluorescence-conjugated immunoassay for platelet activation
US5246832A (en) Platelet analysis in whole blood
CA2173159C (fr) Detection d'un infarctus du myocarde en phase aigue chez un patient
FI113206B (fi) Tiettyjen hemostaattisten häiriöiden diagnoosimenetelmä ja testipakkaus
Ault et al. Analysis of platelets by flow cytometry
Matzdorff et al. Comparison of β-thromboglobulin, flow cytometry, and platelet aggregometry to study platelet activation
US5939276A (en) Flow cytometry assay for heparin-induced thrombocytopenia
Freedman et al. Simple method for differentiating between HLA and platelet‐specific antibodies by flow cytometry
Freedman et al. Random donor platelet crossmatching: comparison of four platelet antibody detection methods
Li et al. A whole‐blood flow cytometric assay for leukocyte CD11b expression using fluorescence signal triggering
EP0221768A2 (fr) Détection de l'activation de T-cellules
Lingenfelter et al. HLA‐B27 screening by flow cytometry
Cragg et al. The expression of cell surface ferritin by peripheral blood lymphocytes and monocytes
EP0725933A1 (fr) Dosage immunologique conjugue a une technique fluorimetrique directe pour mesurer l'activation des plaquettes
Cox et al. Activation-specific neo-antigens on platelets detected by monoclonal antibodies
US5098849A (en) Material and method to reduce non-specific binding of a labelled material
MXPA96004205A (en) Direct immunovation by fluorescence conjugated for the activation of plaque
US5457028A (en) Standard platelet samples and method for preparation thereof

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired